BioMaxima S.A. (WSE:BMX)

Market Cap	53.88M
Revenue (ttm)	59.11M
Net Income (ttm)	649.00K
Shares Out	4.19M
EPS (ttm)	0.15
PE Ratio	85.67
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,282
Average Volume	14,854
Open	12.55
Previous Close	12.35
Day's Range	12.55 - 12.90
52-Week Range	10.70 - 15.65
Beta	0.23
RSI	62.84
Earnings Date	Apr 29, 2026

About BioMaxima

BioMaxima S.A. manufactures and distributes microbiological media, reagents, and equipment for in vitro diagnostics in Poland. Its primary products include analyzers and diagnostic reagents for testing the biochemical parameters of blood and other body fluids; systems for the determination of drug resistance of microorganisms; quick diagnostic tests for detecting infectious diseases, cancer markers, heart attack markers, and addictive substances and readers; urine analysis systems; hematology analyzers and reagents; ionselective analyzers and r...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1997
• Employees: 126
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: BMX

Financial Performance

In 2024, BioMaxima's revenue was 52.85 million, an increase of 12.96% compared to the previous year's 46.79 million. Earnings were 535,000, a decrease of -8.70%.